SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ATIS is on the move!
ATIS 0.1000-47.4%Apr 14 5:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: WWS who wrote (1286)1/14/1998 9:40:00 PM
From: Rick Strange  Read Replies (1) of 2205
 
S&N has been selling Dermagraft in the U.K., Canada and parts of Europe. I suggest that the feedback from their clients has generated that "great faith" regarding the FDA. This also works out well for TC since it is such a small market (1250 estimated patients with III degree burns over 80% of their body in the U.S.). S&N is in 60 countries so the market is suddenly larger. I would anticipate a gap opening...how big is anyone's guess.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext